Physician Assistant · Asheboro, NC
NPI
1598277691
Since 2017
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
360 Sunset Ave
Asheboro, NC, 27203
Phone (336) 625-8410
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
1,613 services
Medicare patients, 2024
276
Average age 75
Drug cost, 2024
$1.7M
1,630 prescriptions
Company payments, 2025
$7,287
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank M Houston Jr. was code 17003 (destruction skin lesion), 444 times for 79 patients. In total Frank M Houston Jr. billed 1,613 services in 47 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 444 | 79 | $3.81 | $1,693 |
| 99213 Office E&M - Established | Office | 224 | 149 | $45.77 | $10K |
| 88305 Surgical Pathology Examination | Office | 192 | 109 | $39.47 | $7,578 |
| 17000 Destruction Skin Lesion | Office | 154 | 100 | $30.56 | $4,706 |
| 11102 Skin Biopsy | Office | 114 | 99 | $49.87 | $5,685 |
| 99214 Office E&M - Established | Office | 72 | 60 | $67.30 | $4,845 |
| 17110 Destruction Skin Lesion | Office | 54 | 41 | $63.83 | $3,447 |
| 96372 Injection Administration | Office | 48 | 12 | $6.98 | $335 |
| 99203 Office E&M - New | Office | 48 | 48 | $56.54 | $2,714 |
| 11103 Skin Biopsy | Office | 41 | 29 | $28.06 | $1,150 |
| 99212 Office E&M - Established | Office | 37 | 36 | $25.43 | $941 |
| 99204 Office E&M - New | Office | 19 | 19 | $80.28 | $1,525 |
| 17282 Destruction Skin Lesion | Office | 15 | 12 | $120.46 | $1,807 |
| 12032 Wound Repair - All Levels | Office | 12 | 11 | $179.00 | $2,148 |
By year: 2022 $53K for 1,398 services; 2023 $59K for 1,627 services; 2024 $61K for 1,613 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 192 | 109 | $39.47 | $7,578 |
Medicare prescription drug claims, 2024
In 2024, the drug Frank M Houston Jr. prescribed most often to Medicare patients was Triamcinolone Acetonide, with 230 prescriptions and refills. In total Frank M Houston Jr. wrote 1,630 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 230 | 236 | 139 | $2,144 |
| Doxycycline Hyclate Generic | 199 | 263 | 81 | $3,569 |
| Clobetasol Propionate Generic | 143 | 146 | 65 | $6,011 |
| Finasteride Generic | 110 | 187 | 23 | $471 |
| Ketoconazole Generic | 94 | 100 | 27 | $1,096 |
| Mupirocin Generic | 83 | 83 | 48 | $670 |
| Dupixent Syringe Dupilumab | 54 | 55 | Under 11 | $207K |
| Fluconazole Generic | 43 | 52 | 31 | $351 |
| Minocycline Hcl Generic | 41 | 41 | Under 11 | $574 |
| Mometasone Furoate Generic | 40 | 40 | 21 | $442 |
| Ammonium Lactate Generic | 39 | 41 | 14 | $506 |
| Hydroxyzine Hcl Generic | 36 | 56 | 13 | $515 |
| Skyrizi Risankizumab-Rzaa | 33 | 89 | Under 11 | $690K |
| Cephalexin Generic | 32 | 34 | 19 | $287 |
| Prednisone Generic | 31 | 31 | 16 | $99.45 |
Brand drugs: 210 claims; generic drugs: 1,420 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank M Houston Jr. $7,287 ($7,287 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $5,112.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $5,112 |
| Genzyme Corporation SNY | 13 | $323 |
| UCB, Inc. UCB.BR | 22 | $284 |
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $281 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 14 | $253 |
| Janssen Biotech, Inc. JNJ | 18 | $238 |
| LEO Pharma Inc. | 11 | $181 |
| Galderma Laboratories, L.P. GALD.SW | 19 | $169 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $79.22 |
| Arcutis Biotherapeutics, Inc. ARQT | 4 | $78.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.